Of mice and men: The factor H protein family and complement regulation

Molecular Immunology

Volumn 67, Issue 1, 2015, Pages 12-20

  Pouw, R B ^a,b   Vredevoogd, D W ^a   Kuijpers, T W ^a,b   Wouters, D ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Complement; Factor H; Human; Mouse; Regulation

Indexed keywords

COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED PROTEIN; FACTOR H LIKE 1; PROTEIN; UNCLASSIFIED DRUG; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; FACTOR H-RELATED PROTEIN 1; PLASMA PROTEIN;

COMPLEMENT ACTIVATION; COMPLEMENT REGULATION; COMPLEMENT SYSTEM; GENE CLUSTER; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SURFACE PROPERTY; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HEMOLYTIC UREMIC SYNDROME; IMMUNOLOGY; MOUSE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOLOGY; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

MUS;

ANIMALS; BLOOD PROTEINS; COMPLEMENT C3; COMPLEMENT C5; COMPLEMENT FACTOR H; GENE EXPRESSION REGULATION; HEMOGLOBINURIA, PAROXYSMAL; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MICE; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY;

EID: 84936984999     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.03.011     Document Type: Review

References (78)

1. Athanasiou Y., Voskarides K., Gale D.P., Damianou L., Patsias C., Zavros M., Maxwell P.H., Cook H.T., Demosthenous P., Hadjisavvas A., Kyriacou K., Zouvani I., Pierides A., Deltas C. Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees. Clin. J. Am. Soc. Nephrol. 2011, 6:1436-1446.
2. Blackmore T.K., Hellwage J., Sadlon T.A., Higgs N., Zipfel P.F., Ward H.M., Gordon D.L. Identification of the second heparin-binding domain in human complement factor H. J. Immunol. 1998, 160:3342-3348.
3. Blackmore T.K., Sadlon T.A., Ward H.M., Lublin D.M., Gordon D.L. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. J. Immunol. 1996, 157:5422-5427.
4. Blaum B.S., Hannan J.P., Herbert A.P., Kavanagh D., Uhrin D., Stehle T. Structural basis for sialic acid-mediated self-recognition by complement factor H. Nat. Chem. Biol. 2015, 11:77-82.
5. Blom A.M., Villoutreix B.O., Dahlback B. Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?. Mol. Immunol. 2004, 40:1333-1346.
6. Cheng Z.Z., Hellwage J., Seeberger H., Zipfel P.F., Meri S., Jokiranta T.S. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H. Mol. Immunol. 2006, 43:972-979.
7. Clark S.J., Perveen R., Hakobyan S., Morgan B.P., Sim R.B., Bishop P.N., Day A.J. Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J. Biol. Chem. 2010, 285:30192-30202.
8. Clark S.J., Ridge L.A., Herbert A.P., Hakobyan S., Mulloy B., Lennon R., Wurzner R., Morgan B.P., Uhrin D., Bishop P.N., Day A.J. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J. Immunol. 2013, 190:2049-2057.
9. Clark S.J., Schmidt C.Q., White A.M., Hakobyan S., Morgan B.P., Bishop P.N. Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration. J. Immunol. 2014, 193:4962-4970.
10. Davila S., Wright V.J., Khor C.C., Sim K.S., Binder A., Breunis W.B., Inwald D., Nadel S., Betts H., Carrol E.D., de G.R., Hermans P.W., Hazelzet J., Emonts M., Lim C.C., Kuijpers T.W., Martinon-Torres F., Salas A., Zenz W., Levin M., Hibberd M.L. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat. Genet. 2010, 42:772-776.
11. Ding J.D., Kelly U., Landowski M., Toomey C.B., Groelle M., Miller C., Smith S.G., Klingeborn M., Singhapricha T., Jiang H., Frank M.M., Bowes R.C. Expression of human complement factor h prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged cfh knockout mice. Am. J. Pathol. 2015, 185:29-42.
12. Eberhardt H.U., Buhlmann D., Hortschansky P., Chen Q., Bohm S., Kemper M.J., Wallich R., Hartmann A., Hallstrom T., Zipfel P.F., Skerka C. Human factor H-related protein 2 (CFHR2) regulates complement activation. PLoS One 2013, 8:e78617.
13. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
14. Esparza-Gordillo J., Soria J.M., Buil A., Almasy L., Blangero J., Fontcuberta J., Rodriguez de Cordoba S. Genetic and environmental factors influencing the human factor H plasma levels. Immunogenetics 2004, 56:77-82.
15. Fakhouri F., Goicoechea de Jorge E., Brune F., Azam P., Cook H.T., Pickering M.C. Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice. Kidney Int. 2010, 78:279-286.
16. Fenaille F., Le M.M., Groseil C., Ramon C., Riande S., Siret L., Bihoreau N. Site-specific N-glycan characterization of human complement factor H. Glycobiology 2007, 17:932-944.
17. Fridkis-Hareli M., Storek M., Mazsaroff I., Risitano A.M., Lundberg A.S., Horvath C.J., Holers V.M. Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases. Blood 2011, 118:4705-4713.
18. Fritsche L.G., Lauer N., Hartmann A., Stippa S., Keilhauer C.N., Oppermann M., Pandey M.K., Kohl J., Zipfel P.F., Weber B.H., Skerka C. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum. Mol. Genet. 2010, 19:4694-4704.
19. Gale D.P., Goicoechea de Jorge E., Cook H.T., Martinez-Barricarte R., Hadjisavvas A., McLean A.G., Pusey C.D., Pierides A., Kyriacou K., Athanasiou Y., Voskarides K., Deltas C., Palmer A., Fremeaux-Bacchi V., Rodriguez de Cordoba S., Maxwell P.H., Pickering M.C. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 2010, 376:794-801.
20. Goicoechea de Jorge E., Caesar J.J., Malik T.H., Patel M., Colledge M., Johnson S., Hakobyan S., Morgan B.P., Harris C.L., Pickering M.C., Lea S.M. Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc. Natl. Acad. Sci. USA 2013, 110:4685-4690.
21. Gordon D.L., Kaufman R.M., Blackmore T.K., Kwong J., Lublin D.M. Identification of complement regulatory domains in human factor H. J. Immunol. 1995, 155:348-356.
22. Hageman G.S., Hancox L.S., Taiber A.J., Gehrs K.M., Anderson D.H., Johnson L.V., Radeke M.J., Kavanagh D., Richards A., Atkinson J., Meri S., Bergeron J., Zernant J., Merriam J., Gold B., Allikmets R., Dean M. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann. Med. 2006, 38:592-604.
23. Hagglund P., Bunkenborg J., Elortza F., Jensen O.N., Roepstorff P. A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J. Proteome Res. 2004, 3:556-566.
24. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
25. Hakobyan S., Harris C.L., Tortajada A., Goicoechea de Jorge E., Garcia-Layana A., Fernandez-Robredo P., Rodriguez de Cordoba S., Morgan B.P. Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: application to assessing risk of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:1983-1990.
26. Harada Y., Bonhomme F., Natsuume-Sakai S., Tomita T., Moriwaki K. Serological survey of complement factor H in common laboratory and wild mice: a new third allotype. Immunogenetics 1989, 29:148-154.
27. Harboe M., Ulvund G., Vien L., Fung M., Mollnes T.E. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin. Exp. Immunol. 2004, 138:439-446.
28. Hebecker M., Alba-Dominguez M., Roumenina L.T., Reuter S., Hyvarinen S., Dragon-Durey M.A., Jokiranta T.S., Sanchez-Corral P., Jozsi M. An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H. J. Immunol. 2013, 191:912-921.
29. Heine-Suner D., Diaz-Guillen M.A., de Villena F.P., Robledo M., Benitez J., Rodriguez de Cordoba S. A high-resolution map of the regulator of the complement activation gene cluster on 1q32 that integrates new genes and markers. Immunogenetics 1997, 45:422-427.
30. Heinen S., Hartmann A., Lauer N., Wiehl U., Dahse H.M., Schirmer S., Gropp K., Enghardt T., Wallich R., Halbich S., Mihlan M., Schlotzer-Schrehardt U., Zipfel P.F., Skerka C. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 2009, 114:2439-2447.
31. Hellwage J., Eberle F., Babuke T., Seeberger H., Richter H., Kunert A., Hartl A., Zipfel P.F., Jokiranta T.S., Jozsi M. Two factor H-related proteins from the mouse: expression analysis and functional characterization. Immunogenetics 2006, 58:883-893.
32. Hughes A.E., Orr N., Esfandiary H., Diaz-Torres M., Goodship T., Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet. 2006, 38:1173-1177.
33. Jacobson A.C., Weis J.H. Comparative functional evolution of human and mouse CR1 and CR2. J. Immunol. 2008, 181:2953-2959.
34. Jokiranta T.S., Cheng Z.Z., Seeberger H., Jozsi M., Heinen S., Noris M., Remuzzi G., Ormsby R., Gordon D.L., Meri S., Hellwage J., Zipfel P.F. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. Am. J. Pathol. 2005, 167:1173-1181.
35. Jokiranta T.S., Hellwage J., Koistinen V., Zipfel P.F., Meri S. Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J. Biol. Chem. 2000, 275:27657-27662.
36. Jozsi M., Oppermann M., Lambris J.D., Zipfel P.F. The C-terminus of complement factor H is essential for host cell protection. Mol. Immunol. 2007, 44:2697-2706.
37. Jozsi M., Richter H., Loschmann I., Skerka C., Buck F., Beisiegel U., Erdei A., Zipfel P.F. FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene. Eur. J. Hum. Genet. 2005, 13:321-329.
38. Kingsmore S.F., Vik D.P., Kurtz C.B., Leroy P., Tack B.F., Weis J.H., Seldin M.F. Genetic organization of complement receptor-related genes in the mouse. J. Exp. Med. 1989, 169:1479-1484.
39. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
40. Kristensen T., Tack B.F. Murine protein H is comprised of 20 repeating units, 61 amino acids in length. Proc. Natl. Acad. Sci. USA 1986, 83:3963-3967.
41. Kristensen T., Wetsel R.A., Tack B.F. Structural analysis of human complement protein H: homology with C4b binding protein, beta 2-glycoprotein I, and the Ba fragment of B2. J. Immunol. 1986, 136:3407-3411.
42. Krych-Goldberg M., Atkinson J.P. Structure-function relationships of complement receptor type 1. Immunol. Rev. 2001, 180:112-122.
43. Kuhn S., Skerka C., Zipfel P.F. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. J. Immunol. 1995, 155:5663-5670.
44. Kuhn S., Zipfel P.F. Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H. Eur. J. Immunol. 1996, 26:2383-2387.
45. Lambris J.D., Ricklin D., Geisbrecht B.V. Complement evasion by human pathogens. Nat. Rev. Microbiol. 2008, 6:132-142.
46. Loirat C., Fremeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet. J. Rare. Dis. 2011, 6:60.
47. McRae J.L., Duthy T.G., Griggs K.M., Ormsby R.J., Cowan P.J., Cromer B.A., McKinstry W.J., Parker M.W., Murphy B.F., Gordon D.L. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J. Immunol. 2005, 174:6250-6256.
48. Mehta G., Ferreira V.P., Skerka C., Zipfel P.F., Banda N.K. New insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseases. Mol. Immunol. 2014, 62:235-248.
49. Miwa T., Song W.C. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases. Int. Immunopharmacol. 2001, 1:445-459.
50. Natsuume-Sakai S., Sudoh K., Kaidoh T., Hayakawa J., Takahashi M. Structural polymorphism of murine complement factor H controlled by a locus located between the Hc and the beta 2M locus on the second chromosome of the mouse. J. Immunol. 1985, 134:2600-2606.
51. Nilsson S.C., Sim R.B., Lea S.M., Fremeaux-Bacchi V., Blom A.M. Complement factor I in health and disease. Mol. Immunol. 2011, 48:1611-1620.
52. Okada M., Kojima A., Takano H., Harada Y., Nonaka M., Nonaka M., Kinoshita T., Seya T., Natsuume-Sakai S. Functional properties of the allotypes of mouse complement regulatory protein, factor H: difference of compatibility of each allotype with human factor I. Mol. Immunol. 1993, 30:841-848.
53. Paixao-Cavalcante D., Hanson S., Botto M., Cook H.T., Pickering M.C. Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase. Mol. Immunol. 2009, 46:1942-1950.
54. Pennesi M.E., Neuringer M., Courtney R.J. Animal models of age related macular degeneration. Mol. Aspects Med. 2012, 33:487-509.
55. Pickering M.C., Goicoechea de Jorge E., Martinez-Barricarte R., Recalde S., Garcia-Layana A., Rose K.L., Moss J., Walport M.J., Cook H.T., Rodriguez de Cordoba S., Botto M. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J. Exp. Med. 2007, 204:1249-1256.
56. Prosser B.E., Johnson S., Roversi P., Herbert A.P., Blaum B.S., Tyrrell J., Jowitt T.A., Clark S.J., Tarelli E., Uhrin D., Barlow P.N., Sim R.B., Day A.J., Lea S.M. Structural basis for complement factor H linked age-related macular degeneration. J. Exp. Med. 2007, 204:2277-2283.
57. Ripoche J., Day A.J., Harris T.J., Sim R.B. The complete amino acid sequence of human complement factor H. Biochem. J. 1988, 249:593-602.
58. Risitano A.M., Notaro R., Pascariello C., Sica M., del V.L., Horvath C.J., Fridkis-Hareli M., Selleri C., Lindorfer M.A., Taylor R.P., Luzzatto L., Holers V.M. The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment. Blood 2012, 119:6307-6316.
59. Rodriguez de Cordoba S., Esparza-Gordillo J., Goicoechea de J.E., Lopez-Trascasa M., Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol. 2004, 41:355-367.
60. Rodriguez de Cordoba S., Tortajada A., Harris C.L., Morgan B.P. Complement dysregulation and disease: from genes and proteins to diagnostics and drugs. Immunobiology 2012, 217:1034-1046.
61. Rohrer B., Coughlin B., Bandyopadhyay M., Holers V.M. Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization. J. Ocul. Pharmacol. Ther. 2012, 28:402-409.
62. Schmid-Kubista K.E., Tosakulwong N., Wu Y., Ryu E., Hecker L.A., Baratz K.H., Brown W.L., Edwards A.O. Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2009, 50:5070-5079.
63. Schmidt C.Q., Bai H., Lin Z., Risitano A.M., Barlow P.N., Ricklin D., Lambris J.D. Rational engineering of a minimized immune inhibitor with unique triple-targeting properties. J. Immunol. 2013, 190:5712-5721.
64. Schmidt C.Q., Herbert A.P., Kavanagh D., Gandy C., Fenton C.J., Blaum B.S., Lyon M., Uhrin D., Barlow P.N. A new map of glycosaminoglycan and C3b binding sites on factor H. J. Immunol. 2008, 181:2610-2619.
65. Schmidt C.Q., Slingsby F.C., Richards A., Barlow P.N. Production of biologically active complement factor H in therapeutically useful quantities. Protein Expr. Purif. 2011, 76:254-263.
66. Schwaeble W., Zwirner J., Schulz T.F., Linke R.P., Dierich M.P., Weiss E.H. Human complement factor H: expression of an additional truncated gene product of 43kDa in human liver. Eur. J. Immunol. 1987, 17:1485-1489.
67. Skerka C., Chen Q., Fremeaux-Bacchi V., Roumenina L.T. Complement factor H related proteins (CFHRs). Mol. Immunol. 2013, 56:170-180.
68. Sofat R., Mangione P.P., Gallimore J.R., Hakobyan S., Hughes T.R., Shah T., Goodship T., D'Aiuto F., Langenberg C., Wareham N., Morgan B.P., Pepys M.B., Hingorani A.D. Distribution and determinants of circulating complement factor H concentration determined by a high-throughput immunonephelometric assay. J. Immunol. Methods 2013, 390:63-73.
69. Tortajada A., Yebenes H., Abarrategui-Garrido C., Anter J., Garcia-Fernandez J.M., Martinez-Barricarte R., Alba-Dominguez M., Malik T.H., Bedoya R., Cabrera P.R., Lopez T.M., Pickering M.C., Harris C.L., Sanchez-Corral P., Llorca O., Rodriguez de Cordoba S. C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation. J. Clin. Invest. 2013, 123:2434-2446.
70. Ufret-Vincenty R.L., Aredo B., Liu X., McMahon A., Chen P.W., Sun H., Niederkorn J.Y., Kedzierski W. Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings. Invest. Ophthalmol. Vis. Sci. 2010, 51:5878-5887.
71. Vik D.P., Keeney J.B., Munoz-Canoves P., Chaplin D.D., Tack B.F. Structure of the murine complement factor H gene. J. Biol. Chem. 1988, 263:16720-16724.
72. Vik D.P., Munoz-Canoves P., Kozono H., Martin L.G., Tack B.F., Chaplin D.D. Identification and sequence analysis of four complement factor H-related transcripts in mouse liver. J. Biol. Chem. 1990, 265:3193-3201.
73. Walport M.J. Complement First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
74. Wang Y., Wu S.L., Hancock W.S. Approaches to the study of N-linked glycoproteins in human plasma using lectin affinity chromatography and nano-HPLC coupled to electrospray linear ion trap--Fourier transform mass spectrometry. Glycobiology 2006, 16:514-523.
75. Weismann D., Hartvigsen K., Lauer N., Bennett K.L., Scholl H.P., Charbel I.P., Cano M., Brandstatter H., Tsimikas S., Skerka C., Superti-Furga G., Handa J.T., Zipfel P.F., Witztum J.L., Binder C.J. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011, 478:76-81.
76. Zhang H., Liu A.Y., Loriaux P., Wollscheid B., Zhou Y., Watts J.D., Aebersold R. Mass spectrometric detection of tissue proteins in plasma. Mol. Cell Proteomics 2007, 6:64-71.
77. Zhao J., Wu H., Khosravi M., Cui H., Qian X., Kelly J.A., Kaufman K.M., Langefeld C.D., Williams A.H., Comeau M.E., Ziegler J.T., Marion M.C., Adler A., Glenn S.B., Alarcon-Riquelme M.E., Pons-Estel B.A., Harley J.B., Bae S.C., Bang S.Y., Cho S.K., Jacob C.O., Vyse T.J., Niewold T.B., Gaffney P.M., Moser K.L., Kimberly R.P., Edberg J.C., Brown E.E., Alarcon G.S., Petri M.A., Ramsey-Goldman R., Vila L.M., Reveille J.D., James J.A., Gilkeson G.S., Kamen D.L., Freedman B.I., Anaya J.M., Merrill J.T., Criswell L.A., Scofield R.H., Stevens A.M., Guthridge J.M., Chang D.M., Song Y.W., Park J.A., Lee E.Y., Boackle S.A., Grossman J.M., Hahn B.H., Goodship T.H., Cantor R.M., Yu C.Y., Shen N., Tsao B.P. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet. 2011, 7:e1002079.
78. Zipfel P.F., Edey M., Heinen S., Jozsi M., Richter H., Misselwitz J., Hoppe B., Routledge D., Strain L., Hughes A.E., Goodship J.A., Licht C., Goodship T.H., Skerka C. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet. 2007, 3:e41.